971
Views
53
CrossRef citations to date
0
Altmetric
Review Paper

Geographic distribution of ATP7B mutations in Wilson disease

&
Pages 1-8 | Received 17 Mar 2014, Accepted 06 May 2015, Published online: 24 Jul 2015

References

  • Abdel Ghaffar TY, Elsayed SM, Elnaghy S, Shadeed A, Elsobky ES, Schmidt H. 2011. Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients. BMC Pediatrics 11:56
  • Aggarwal A, Chandhok G, Todorov T, Parekh S, Tilve S, Zibert A, Bhatt M, Schmidt HH. 2013. Wilson disease mutation pattern with genotype-phenotype correlations from western India: confirmation of p.C271* as a Common Indian Mutation and Identification of 14 Novel Mutations. Ann Hum Genet 77:299–307
  • Al Jumah M, Majumdar R, Al Rajeh S, Awada A, Al Zaben A, Al Traif I, Al Jumah AR, Rehana Z. 2004. A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations. Eur J Neurol 11:121–124
  • Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. 2007. Wilson's Disease. Lancet 369:397–408
  • Bertinato J, L'Abbé MR. 2004. Maintaining copper homeostasis: regulation of copper-trafficking proteins in response to copper deficiency or overload. J Nutr Biochem 15:316–322
  • Beyersdorff A, Findeisen A. 2006. Morbus Wilson: case report of a two-year-old child as first manifestation. Scand J Gastroenterol 41:496–497
  • Bost M, Piguet-Lacroix G, Parant F, Wilson CM. 2012. Molecular analysis of Wilson patients: direct sequencing and MLPA analysis in the ATP7B gene and Atox1 and COMMD1 gene analysis. J Trace Elem Med Biol 26:97–101
  • Brewer GJ, Dick RD, Johnson V, Wang Y, Yuzbasiyan-Gurkan V, Kluin K, Fink JK, Aisen A. 1994. Treatment of Wilson's disease with Ammonium Tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. Arch Neurol 51:545–554
  • Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. 1993. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5:327–337
  • Caca K, Ferenci P, Kühn HJ, Polli C, Willgerodt H, Kunath B, Hermann W, Mössner J, Berr F. 2001. High prevalence of the H1069Q mutation in east German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol 35:575–581
  • Coffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, Klaffke S, et al. 2013. A genetic study of Wilson's disease in the United Kingdom. Brain J Neurol 136:1476–1487
  • Culotta VC, Gitlin JD. 2001. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, Antonarakis SE, Ballabio A, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. p 3105–26
  • Cumings JN. 1948. The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain 71:410–415
  • Dedoussis GV, Genschel J, Sialvera TE, Bochow B, Manolaki N, Manios Y, Tsafantakis E, Schmidt H. 2005. Wilson disease: high prevalence in a mountainous area of Crete. Ann Hum Genet 69:268–274
  • Deguti MM, Genschel J, Cancado EL, Barbosa ER, Bochow B, Mucenic M, Porta G, et al. 2004. Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Hum Mutat 23:398
  • El Balkhi S, Trocello JM, Poupon J, Chappuis P, Massicot F, Girardot-Tinant N, Woimant F. 2011. Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson's disease diagnosis. Clin Chim Acta 412:2254–2260
  • Ferenci P. 2006. Regional distribution of mutations of the ATP7B gene in patients with Wilson Disease: impact on genetic testing. Hum Genet 120:151–159
  • Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky M, Cox D, Berr F. 2003. Diagnosis and phenotypic classification of Wilson disease. Liver Int 23:139–142
  • Ferenci P, Członkowska A, Merle U, Ferenc S, Gromadzka G, Yurdaydin C, Vogel W, Bruha R, Schmidt HT, Stremmel W. 2007. Late-onset Wilson's disease. Gastroenterology 132:1294–1298
  • Figus A, Angius A, Loudianos G, Bertini C, Dessi V, Loi A, Deiana M, et al. 1995. Molecular pathology and haplotype analysis of Wilson disease in mediterranean populations. Am J Hum Genet 57:1318–1324
  • Firneisz G, Lakatos PL, Szalay F, Polli C, Glant TT, Ferenci P. 2002. Common mutations of ATP7B in Wilson disease patients from Hungary. Am J Med Genet 108:23–28
  • Frydman M, Bonné-Tamir B, Farrer LA, Conneally PM, Magazanik A, Ashbel S, Goldwitch Z. 1985. Assignment of the gene for Wilson disease to chromosome 13: linkage to the Esterase D locus. Proc Natl Acad Sci USA 82:1819–1821
  • García-Villarreal L, Daniels S, Shaw SH, Cotton D, Galvin M, Geskes J, Bauer P, Sierra-Hernández A, Buckler A, Tugores A. 2000. High prevalence of the very rare Wilson disease gene mutation Leu708Pro in the island of Gran Canaria (Canary Islands, Spain): a genetic and clinical study. Hepatology 32:1329–1336
  • Gojová L, Jansová E, Külm M, Pouchlá S, Kozák L. 2008. Genotyping Microarray as a novel approach for the detection of ATP7B gene mutations in patients with Wilson disease. Clin Genet 73:441–452
  • Gromadzka G, Schmidt HH, Genschel J, Bochow B, Rodo M, Tarnacka B, Litwin T, Chabik G, Członkowska A. 2005. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease. Clin Genet 68:524–532
  • Gu YH, Kodama H, Du SL, Gu QJ, Sun HJ, Ushijima H. 2003. Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson's disease. Clin Genet 64:479–484
  • Gupta A, Aikath D, Neogi R, Datta S, Basu K, Maity B, Trivedi R, et al. 2005. Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients. Hum Genet 118:49–57
  • Gupta A, Chattopadhyay I, Dey S, Nasipuri P, Das SK, Gangopadhyay PK, Ray K. 2007. Molecular pathogenesis of Wilson disease among indians: a perspective on mutation spectrum in ATP7B gene, prevalent defects, clinical heterogeneity and implication towards diagnosis. Cell Mol Neurobiol 27:1023–1033
  • Hellman NE, Gitlin JD. 2002. Ceruloplasmin metabolism and function. Annu Rev Nutr 22:439–458
  • Iacob R, Iacob S, Nastase A, Vagu C, Ene AM, Constantinescu A, Anghel D, et al. 2012. The His1069Gln Mutation in the ATP7B gene in Romanian patients with Wilson's disease referred to a tertiary gastroenterology center. J Gastrointestin Liver Dis 21:181–185
  • Ivanova-Smolenskaya IA, Ovchinnikov IV, Karabanov AV, Deineko NL, Poleshchuk VV, Markova ED, Illarioshkin SN. 1999. The His1069Gln mutation in the ATP7B gene in Russian patients with Wilson disease. J Med Genet 36:174
  • Kenney SM, Cox DW. 2007. Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum Mutat 28:1171–1177
  • Kim GH, Yang JY, Park JY, Lee JJ, Kim JH, Yoo HW. 2008. Estimation of Wilson's disease incidence and carrier frequency in the Korean population by screening ATP7B major mutations in newborn filter papers using the SYBR green intercalator method based on the amplification refractory mutation system. Genet Test 12:395–399
  • Kumar S, Thapa B, Kaur G, Prasad R. 2007. Analysis of most common mutations R778G, R778L, R778W, I1102T and H1069Q in Indian Wilson disease patients: correlation between genotype/phenotype/copper atpase activity. Mol Cell Biochem 294:1–10
  • Kumar S, Thapa BR, Kaur G, Prasad R. 2005. Identification and molecular characterization of 18 novel mutations in the ATP7B gene from Indian Wilson disease patients: Genotype. Clin Genet 67:443–445
  • Kuppala D, Deng J, Brewer GJ, Wang MM, Borjigin J. 2009. Wilson disease mutations in the American population : identification of five novel mutations in ATP7B. Open Hepatol J 18:1–4
  • La Fontaine S, Mercer JF. 2007. Trafficking of the Copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch Biochem Biophys 463:149–167
  • Lee CC, Wu JY, Tsai FJ, Kodama H, Abe T, Yang CF, Tsai CH. 2000. Molecular analysis of Wilson disease in Taiwan: identification of one novel mutation and evidence of haplotype-mutation association. J Hum Genet 45:275–279
  • Li XH, Lu Y, Ling Y, Fu QC, Xu J, Zang GQ, Zhou F, et al. 2011. Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations. BMC Med Genet 12:6
  • Lin CW, Er TK, Tsai FJ, Liu TC, Shin PY, Chang JG. 2010. Development of a high-resolution melting method for the screening of Wilson Disease-Related ATP7B gene mutations. Clin Chim Acta 411:1223–1231
  • Linder MC, editor. 1991. Biochemistry of copper. New York: Plenum Press
  • Loudianos G, Dessi V, Lovicu M, Angius A, Altuntas B, Giacchino R, Marazzi M, et al. 1999a. Mutation analysis in patients of mediterranean descent with Wilson disease: identification of 19 novel mutations. J Med Genet 36:833–836
  • Loudianos G, Dessi V, Lovicu M, Angius A, Figus A, Lilliu F, De Virgiliis S, et al. 1999b. Molecular characterization of Wilson disease in the Sardinian population – evidence of a founder effect. Hum Mutat 14:294–303
  • Loudianos G, Kostic V, Solinas P, Lovicu M, Dessì V, Svetel M, Major T, Cao A. 2003. Characterization of the molecular defect in the ATP7B gene in Wilson disease patients from Yugoslavia. Genet Test 7:107–112
  • Machado AA, Deguti MM, Genschel J, Cançado EL, Bochow B, Schmidt H, Barbosa ER. 2008. Neurological manifestations and ATP7B mutations in Wilson's disease. Parkinsonism Relat Disord 14:246–249
  • Mak CM, Lam CW, Lai ST, Hui Y, Tam S. 2008. Rapid diagnosis of Wilson disease by a 28-mutation panel: real-time amplification refractory mutation system in diagnosing acute Wilsonian liver failure. Clin Chim Acta 398:39–42
  • Manolaki N, Nikolopoulou G, Daikos GL, Panagiotakaki E, Tzetis M, Roma E, Kanavakis E, Syriopoulou VP. 2009. Wilson disease in children: analysis of 57 Cases. J Pediatr Gastroenterol Nutr 48:72–77
  • Margarit E, Bach V, Gómez D, Bruguera M, Jara P, Queralt R, Ballesta F. 2005. Mutation analysis of Wilson disease in the Spanish population – identification of a prevalent substitution and eight novel mutations in the ATP7B gene. Clinl Genet 68:61–68
  • Møller LB, Horn N, Jeppesen TD, Vissing J, Wibrand F, Jennum P, Ott P. 2011. Clinical presentation and mutations in Danish patients with Wilson disease. Eur J Hum Genet 935–941
  • Okada T, Shiono Y, Hayashi H, Satoh H, Sawada T, Suzuki A, Takeda Y, et al. 2000. Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson's disease. Hum Mutat 15:454–462
  • Panagiotakaki E, Tzetis M, Manolaki N, Loudianos G, Papatheodorou A, Manesis E, Nousia-Arvanitakis S, et al. 2004. Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B). Am J Med Genet Part A 131:168–173
  • Petrukhin K, Lutsenko S, Chernov I, Ross BM, Kaplan JH, Gilliam TC. 1994. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: Genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 3:1647–1656
  • Roberts EA, Schilsky ML. 2003. A practice guideline on Wilson disease. Hepatology 37:1475–1492
  • Roberts EA, Schilsky ML. 2008. Diagnosis and treatment of Wilson disease: an update. Hepatology 47:2089–2111
  • Rumpel A. 1913. Ueber das wesen und die bedeutung der leberveranderungen und der pigmentierunen bie den damitverbundenen fallen von pseu dosklerose, zugleich ein beitrag zur lehre von der pseudosklerose (Westphal-Strumpell). Dtsch Z Nervenheilk 49:54–73
  • Santhosh S, Shaji RV, Eapen CE, Jayanthi V, Malathi S, Chandy M, Stanley M, et al. 2006. ATP7B mutations in families in a predominantly southern Indian cohort of Wilson's disease patients. Ind J Gastroenterol 25:277–282
  • Schmidt HH. 2009. Role of genotyping in Wilson's disease. J Hepatol 50:449–452
  • Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, Parano E, et al. 1997. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 61:317–328
  • Simsek Papur O, Akman SA, Cakmur R, Terzioglu O. 2013. Mutation analysis of ATP7B gene in Turkish Wilson disease patients: identification of five novel mutations. Eur J Med Genet 56:175–179
  • Stapelbroek JM, Bollen CW, van Amstel JK, van Erpecum KJ, van Hattum J, van den Berg LH, Klomp LW, Houwen RH. 2004. The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis. J Hepatol 41:758–763
  • Sternlieb I. 1990. Perspectives on Wilson's disease. Hepatology 12:1234–1239
  • Sternlieb I, Van den Hamer CJ, Morell AG, Alpert S, Gregoriadis G, Scheinberg IH. 1973. Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular Degeneration). Gastroenterology 64:99–105
  • Stohs SJ, Bagchi D. 1995. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 18:321–336
  • Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, et al. 1993. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5:344–350
  • Tatsumi Y, Hattori A, Hayashi H, Ikoma J, Kaito M, Imoto M, Wakusawa S, et al. 2010. Current state of Wilson disease patients in Central Japan. Intern Med 49:809–815
  • Terada K, Aiba N, Yang XL, Iida M, Nakai M, Miura N, Sugiyama T. 1999. Biliary excretion of copper in LEC rat after introduction of copper transporting P-type ATPase, ATP7B. FEBS Lett 448:53–56
  • Terada K, Nakako T, Yang XL, Iida M, Aiba N, Minamiya Y, Nakai M, et al. 1998. Restoration of holoceruloplasmin synthesis in LEC Rat after infusion of recombinant adenovirus bearing WND cDNA. J Biol Chem 273:1815–1820
  • Thomas GR, Roberts EA, Walshe JM, Cox DW. 1995. Haplotypes and mutations in Wilson disease. Am J Hum Genet 56:1315–1319
  • Todorov T, Savov A, Jelev H, Panteleeva E, Konstantinova D, Krustev Z, Mihaylova V, et al. 2005. Spectrum of mutations in the Wilson disease gene (ATP7B) in the Bulgarian population. Clin Genet 68:474–476
  • Trocello JM, El Balkhi S, Woimant F, Girardot-Tinant N, Chappuis P, Lloyd C, Poupon J. 2014. Relative exchangeable copper: a promising tool for family screening in Wilson disease. Move Disord 29:558–562
  • Turnlund J R. 1998. Human whole-body copper metabolism. Am J Clin Nutr 67:960s–964s
  • Vrabelova S, Letocha O, Borsky M, Kozak L. 2005. Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease. Mol Genet Metab 86:277–285
  • Walshe JM. 1956. Wilson's disease; new oral therapy. Lancet 270:25–26
  • Walshe JM. 2009. The conquest of Wilson's disease. Brain J Neurol 132:2289–2295
  • Wan L, Tsai CH, Hsu CM, Huang CC, Yang CC, Liao CC, Wu CC, et al. 2010. Mutation analysis and characterization of alternative splice variants of the Wilson disease gene ATP7B. Hepatology 52:1662–1670
  • Wilson SAK. 1912. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 34:295–507
  • Wu Z, Wang N, Murong S, Lin M. 2000. Identification and analysis of mutations of the Wilson disease gene in Chinese population. Chin Med J 113:40–43
  • Wu ZY, Lin MT, Murong SX, Wang N. 2003. Molecular diagnosis and prophylactic therapy for presymptomatic Chinese patients with Wilson disease. Arch Neurol 60:737–741
  • Yamaguchi Y, Heiny ME, Gitlin JD. 1993. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 197:271–277
  • Yoo HW. 2002. Identification of novel mutations and the three most common mutations in the human ATP7B gene of Korean patients with Wilson disease. Genet Med 4:43–48
  • Zali N, Mohebbi SR, Esteghamat S, Chiani M, Haghighi MM, Hosseini-Asl SM, Derakhshan F, et al. 2011. Prevalence of ATP7B gene mutations in Iranian patients with Wilson disease. Hep Monthly 11:890–894
  • Zappu A, Lepori MB, Incollu S, Noli MC, De Virgiliis S, Cao A, Loudianos G. 2010. Development of TaqMan allelic specific discrimination assay for detection of the most common Sardinian Wilson's disease mutations. Implications for genetic screening. Mol Cell Probes 24:233–235

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.